Oblon, Spivak's Eric Schweibenz quoted in National Law Journal's Article "Big Pharma Tries A New Forum: The ITC"

March 18, 2011 – In The News
National Law Journal, March 18, 2011

Oblon, Spivak's Eric Schweibenz is quoted in the National Law Journal's article "Big Pharma Tries A New Forum: The ITC" regarding institution of a Section 337 investigation at the U.S. International Trade Commission involving, among others, Eli Lilly and Co. Mr. Schweibenz commented on why companies typically select the ITC over district court as a forum for resolving intellectual property disputes and whether this particular matter may signal the start of a new trend.